Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Systemic lupus erythematosus is an autoimmune disease causing diverse symptoms and major organ involvement.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Nanoparticles can make cosmetics more effective but have challenges like cost and safety.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

RADA16 is a promising material for tissue repair and regenerative medicine but needs improvement in strength and cost.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Scientists have made progress in growing mini-organs and regenerating parts of the skin, with plans to treat hair loss in a future trial.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.